BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sinha A, Bagga A, Banerjee S, Mishra K, Mehta A, Agarwal I, Uthup S, Saha A, Mishra OP; Expert Group of Indian Society of Pediatric Nephrology. Steroid Sensitive Nephrotic Syndrome: Revised Guidelines. Indian Pediatr 2021;58:461-81. [DOI: 10.1007/s13312-021-2217-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Mathew G, Sinha A, Ahmed A, Grewal N, Khandelwal P, Hari P, Bagga A. Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial. Pediatr Nephrol. [DOI: 10.1007/s00467-022-05475-8] [Reference Citation Analysis]
2 Hariharan R, Krishnamurthy S, Kaliaperumal S, Karunakar P, Deepthi B. Incidence and predictive risk factors for ophthalmological complications in children with nephrotic syndrome receiving long-term oral corticosteroids: a cohort study. Paediatr Int Child Health 2021;:1-7. [PMID: 34711131 DOI: 10.1080/20469047.2021.1983315] [Reference Citation Analysis]
3 Mantan M, Kansal A, Swarnim S. Effectiveness of a low dose prednisolone regimen for treatment of relapses in children with steroid sensitive nephrotic syndrome. Indian J Nephrol 2022;0:0. [DOI: 10.4103/ijn.ijn_463_21] [Reference Citation Analysis]
4 Mathew G, George AS, Deepthi RV, Rose W, Verghese VP, Varghese R, Veeraraghavan B, Agarwal I. Epidemiology and outcomes of pneumococcal sepsis in children with nephrotic syndrome in a developing country. Pediatr Nephrol. [DOI: 10.1007/s00467-022-05550-0] [Reference Citation Analysis]
5 Vasudevan A, Thergaonkar R, Mantan M, Sharma J, Khandelwal P, Hari P, Sinha A, Bagga A; Expert Group of Indian Society of Pediatric Nephrology. Consensus Guidelines on Management of Steroid-Resistant Nephrotic Syndrome. Indian Pediatr 2021;58:650-66. [DOI: 10.1007/s13312-021-2262-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
6 Fujinaga S, Endo S, Morishita T, Takemasa Y, Onuki Y, Sakuraya K, Hirano D. Predictors of Treatment Response and Long-Term Outcomes in Young Children with Steroid-Dependent Nephrotic Syndrome Treated with High-Dose Mizoribine as First-Line Steroid-Sparing Agent. Tohoku J Exp Med 2022;256:85-91. [DOI: 10.1620/tjem.256.85] [Reference Citation Analysis]